Amdocs (NASDAQ:DOX) Sees Unusually-High Trading Volume – Should You Buy?

Shares of Amdocs Limited (NASDAQ:DOXGet Free Report) saw unusually-high trading volume on Tuesday . Approximately 1,843,800 shares were traded during trading, an increase of 132% from the previous session’s volume of 795,527 shares.The stock last traded at $75.3350 and had previously closed at $75.55.

Analyst Upgrades and Downgrades

Several brokerages have commented on DOX. Weiss Ratings restated a “hold (c)” rating on shares of Amdocs in a report on Thursday, October 30th. Wall Street Zen lowered Amdocs from a “buy” rating to a “hold” rating in a report on Saturday, November 8th. Stifel Nicolaus decreased their price objective on Amdocs from $100.00 to $97.00 and set a “buy” rating for the company in a report on Wednesday, November 12th. Bank of America dropped their target price on Amdocs from $100.00 to $97.00 and set a “buy” rating on the stock in a research report on Wednesday, November 12th. Finally, Wolfe Research restated a “peer perform” rating on shares of Amdocs in a research note on Thursday, November 13th. Two research analysts have rated the stock with a Buy rating and two have given a Hold rating to the company’s stock. Based on data from MarketBeat, the company presently has a consensus rating of “Moderate Buy” and an average price target of $97.00.

Check Out Our Latest Research Report on DOX

Amdocs Stock Up 0.6%

The firm has a market capitalization of $8.63 billion, a P/E ratio of 15.14, a PEG ratio of 1.27 and a beta of 0.43. The firm’s 50 day moving average is $80.68 and its two-hundred day moving average is $85.87. The company has a debt-to-equity ratio of 0.23, a current ratio of 1.17 and a quick ratio of 1.22.

Amdocs (NASDAQ:DOXGet Free Report) last announced its quarterly earnings results on Tuesday, November 11th. The technology company reported $1.83 EPS for the quarter, beating analysts’ consensus estimates of $1.82 by $0.01. The firm had revenue of $1.15 billion during the quarter, compared to analysts’ expectations of $1.15 billion. Amdocs had a net margin of 12.46% and a return on equity of 19.78%. The company’s revenue for the quarter was down 9.0% compared to the same quarter last year. During the same quarter last year, the company posted $1.70 earnings per share. Amdocs has set its FY 2026 guidance at 7.270-7.550 EPS and its Q1 2026 guidance at 1.730-1.790 EPS. Research analysts predict that Amdocs Limited will post 6.21 EPS for the current year.

Amdocs Dividend Announcement

The firm also recently announced a quarterly dividend, which will be paid on Friday, January 30th. Stockholders of record on Wednesday, December 31st will be paid a dividend of $0.527 per share. This represents a $2.11 annualized dividend and a dividend yield of 2.8%. The ex-dividend date is Wednesday, December 31st. Amdocs’s payout ratio is currently 41.78%.

Institutional Investors Weigh In On Amdocs

Hedge funds have recently added to or reduced their stakes in the business. Allworth Financial LP lifted its holdings in Amdocs by 9.3% during the 3rd quarter. Allworth Financial LP now owns 2,570 shares of the technology company’s stock worth $211,000 after purchasing an additional 218 shares during the last quarter. CIBC Private Wealth Group LLC lifted its holdings in shares of Amdocs by 190.2% during the third quarter. CIBC Private Wealth Group LLC now owns 595 shares of the technology company’s stock worth $49,000 after buying an additional 390 shares in the last quarter. CIBC Bancorp USA Inc. bought a new stake in shares of Amdocs in the third quarter valued at about $502,000. Caitong International Asset Management Co. Ltd boosted its position in shares of Amdocs by 68.4% in the third quarter. Caitong International Asset Management Co. Ltd now owns 795 shares of the technology company’s stock valued at $65,000 after acquiring an additional 323 shares during the period. Finally, Advisory Services Network LLC acquired a new position in shares of Amdocs in the third quarter valued at about $42,000. Institutional investors and hedge funds own 92.02% of the company’s stock.

About Amdocs

(Get Free Report)

Amdocs Limited, through its subsidiaries, provides software and services worldwide. It designs, develops, operates, implements, supports, and markets open and modular cloud portfolio. The company provides CES23, a 5G and cloud-native microservices-based market-leading customer experience suite, that enables service providers to build, deliver, and monetize advanced services; Amdocs Subscription Marketplace, a software-as-a-service-based platform that includes an expansive network of pre-integrated digital services, such as media, gaming, eLearning, sports, and retail to security and business services; the monetization suite for charging, billing, policy, and revenue management; Intelligent networking suite with a set of modular, flexible, and open service lifecycle management capabilities for network automation journeys; amAIz, a telco GenAI framework; Amdocs Digital Brands Suite, a pre-integrated digital business suite; and Amdocs eSIM Cloud for service providers.

Recommended Stories

Receive News & Ratings for Amdocs Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Amdocs and related companies with MarketBeat.com's FREE daily email newsletter.